Development

Next-Gen Therapies Drive Development Technologies

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.

Picodroplet Technology Applications in Cell Line Development

Miniaturized high-throughput screening is applicable to bispecific antibody development.

MilliporeSigma Licenses CRISPR-Cas9 Technology to Cellecta

October 11, 2021

MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, signed an agreement with Cellecta to license its genome-editing tool.

Pfizer Agrees to License Agreement with Voyager Therapeutics

October 08, 2021

Pfizer may pay up to $630 million for access to Voyager’s novel AAV capsids in transgene research.

MilliporeSigma Launches Excipient Platform for Protein-Based Therapies

October 06, 2021

New excipients for protein-based drug products reduce viscosity while maintaining protein stability.

Sunovion, Sumitomo Dainippon, and Otsuka Enter Development and Commercialization Collaboration

October 06, 2021

The collaboration between Sunovion, Sumitomo Dainippon, and Otsuka will focus on four compounds designed to treat neuropsychiatric health conditions.

Merck and Ridgeback Biotherapeutics’ Oral Antiviral COVID-19 Treatment Reduces Risk of Hospitalization or Death by 50%

October 05, 2021

Merck and Ridgeback Biotherapeutics' oral antiviral medication reduced the risk of hospitalization or death from COVID-19 by 50% relative to placebo in a Phase III clinical study.

Selecta Biosciences and Takeda Announce Gene Therapy Platform Licensing Agreement

October 04, 2021

Takeda will use Selecta Bioscience’s ImmTOR platform to develop gene therapies for lysosomal storage disorders.

Next-Gen Technologies Tackle Drug Delivery Challenges

October 02, 2021

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Trends in Outsourcing of Bioprocess Development

October 02, 2021

Speed-to-market, capacity, technology development, and increased investment top the list.

Getting a Nose for Vaccines

October 02, 2021

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

New Beginnings

October 01, 2021

Change of roster does not change the goal line. We are all patients first.